Zhongdaixi Zheng

机构：National Medical Products Administration, Panyu Hospital of Chinese Medicine, Southern Medical University

发表论文 20 篇 · 总被引 1420 次 · h-index 11

代表论文

• Regional variation limits applications of healthy gut microbiome reference ranges and disease models (2018 · Nature Medicine · 被引 1001)
• Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis (2018 · Microbiome · 被引 192)
• Author Correction: Regional variation limits applications of healthy gut microbiome reference ranges and disease models (2018 · Nature Medicine · 被引 35)
• Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts (2020 · BMC Complementary Medicine and Therapies · 被引 33)
• Soyasaponin A 2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice (2021 · Molecular Nutrition & Food Research · 被引 29)
• Large-scale characterisation of the pregnancy vaginal microbiome and sialidase activity in a low-risk Chinese population (2021 · npj Biofilms and Microbiomes · 被引 27)